Aurora Cannabis (TSE:ACB) Stock Price Down 5.5% – Here’s Why

Aurora Cannabis Inc. (TSE:ACB)’s stock price traded down 5.5% during mid-day trading on Thursday . The company traded as low as C$4.89 and last traded at C$4.94. 651,864 shares traded hands during mid-day trading, an increase of 69% from the average session volume of 386,382 shares. The stock had previously closed at C$5.23.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group set a C$10.00 price target on Aurora Cannabis and gave the stock a “buy” rating in a research note on Tuesday, January 27th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of C$9.25.

Aurora Cannabis Trading Down 13.6%

The company has a debt-to-equity ratio of 25.02, a quick ratio of 2.48 and a current ratio of 3.06. The firm has a market cap of C$267.25 million, a P/E ratio of -3.01 and a beta of 0.40. The firm has a 50 day simple moving average of C$4.85 and a 200 day simple moving average of C$5.85.

Aurora Cannabis (TSE:ACB) last posted its earnings results on Wednesday, February 4th. The company reported C$0.03 earnings per share (EPS) for the quarter. Aurora Cannabis had a negative net margin of 1.69% and a negative return on equity of 1.15%. The business had revenue of C$94.19 million for the quarter. On average, equities research analysts predict that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.